Zobrazeno 1 - 7
of 7
pro vyhledávání: '"József, Vachaja"'
Autor:
Andrea, Uhlyarik, Violetta, Piurkó, Zsuzsanna, Pápai, Erzsébet, Rásó, Erika, Lahm, Edina, Kiss, Márta, Sikter, József, Vachaja, Laura, Vízkeleti, István, Kenessey, József, Tímár
Publikováno v:
Magyar onkologia. 65(2)
Negative predictive markers of the anti-EGFR antibody therapies are RAS or BRAF mutations, while left sidedness can be considered as a positive predictor. Here we analyzed 97 wild type RAS metastatic colorectal cancers looking for the prognostic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4855078d760ed6e7545b4950ccdc746f
https://pubmed.ncbi.nlm.nih.gov/34081760
https://pubmed.ncbi.nlm.nih.gov/34081760
Autor:
Andrea Uhlyarik, Violetta Piurkó, Erika Lahm, Marta Sikter, József Tímár, Erzsébet Rásó, István Kenessey, Edina Kiss, József Vachaja, Zsuzsanna Papai
Publikováno v:
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 614 (2020)
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 614 (2020)
The selection of colorectal cancer patients for anti-epidermal growth factor receptor (EGFR) antibody therapy is based on the determination of their RAS mutation status&mdash
a strongly negative predictive factor&mdash
since the protein tar
a strongly negative predictive factor&mdash
since the protein tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d190426d31e31d1a3ad145b662bbab
https://doi.org/10.3390/cancers12030614
https://doi.org/10.3390/cancers12030614
Autor:
Violetta Piurkó, József Tímár, Laura Vízkeleti, Edina Kiss, Zs Pápai, István Kenessey, Marta Sikter, Erika Lahm, Andrea Uhlyarik, József Vachaja, Erzsébet Rásó
Publikováno v:
Pathology oncology research : POR. 26(3)
Right- and left-sided colorectal cancers (RSCRC and LSCRC, respectively) are different developmentally, genetically and prognostically. Clinical data also indicate that they respond differently to anti-EGFR therapies. The role of EGFR protein express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::641581d06371a59cc4776b4d62bdf9b0
https://pubmed.ncbi.nlm.nih.gov/30612313
https://pubmed.ncbi.nlm.nih.gov/30612313
Autor:
ANDREA, UHLYARIK, VIOLETTA, PIURKÓ, ZSUZSANNA, PÁPAI, ERZSÉBET, RÁSÓ, ERIKA, LAHM, EDINA, KISS, MÁRTA, SIKTER, JÓZSEF, VACHAJA, LAURA, VÍZKELETI, ISTVÁN, KENESSEY, JÓZSEF, TÍMÁR
Publikováno v:
Magyar Onkologia; 2021, Vol. 65 Issue 2, p121-127, 7p
Publikováno v:
Orvosi Hetilap. 155:194-198
Although the incidence of neuroendocrine tumours is low, their prevalence is high due to the usually slow course of the disease. Between July 1, 2008 and July 1, 2013 the authors evaluated 56 patients with well-differentiated or moderately differenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c49211cbd131a4b3381d201bdd924ea
https://doi.org/10.1556/oh.2014.29818
https://doi.org/10.1556/oh.2014.29818
Autor:
József Tímár, Edina Kiss, István Kenessey, Andrea Uhlyarik, Erzsébet Rásó, Violetta Piurkó, József Vachaja, Zsuzsa Papai, Erika Lahm, Marta Sikter
Publikováno v:
Journal of Clinical Oncology. 36:e15548-e15548
e15548Background: Anti-EGFR monoclonal antibody therapy is a standard treatment of advanced colorectal cancer. Unlike in case of other target therapies the target of anti-EGFR monoclonal antibodies...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3122c696d81f7d863785dce9ff979236
https://doi.org/10.1200/jco.2018.36.15_suppl.e15548
https://doi.org/10.1200/jco.2018.36.15_suppl.e15548
Autor:
Edina, Kiss, Erika, Lahm, József, Vachaja, Péter, Nagy, Péter, Bazsó, Zsolt, Fekete, Zoltán, Takácsi-Nagy, Zsuzsanna, Pápai
Publikováno v:
Magyar onkologia. 57(4)
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults. The current standard therapy includes surgical resection or biopsy, followed by a combination of radiation and chemotherapy with temozolomide. After progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6778ad547bbb59a2a28553227e5bfb52
https://pubmed.ncbi.nlm.nih.gov/24353992
https://pubmed.ncbi.nlm.nih.gov/24353992